Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Improving IL12 immunotherapy in glioblastoma by targeting the long noncoding RNA INCR1

Journal of Neuro-Oncology(2025)10.1007/s11060-025-04978-2Source: DataRank Database

Improving IL12 immunotherapy in glioblastoma by targeting the long noncoding RNA INCR1 is a research paper published in Journal of Neuro-Oncology (2025). On theSindex it has a DataRank of 0. It has been cited 6 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access6 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 2.99)OA: hybridTopics (35)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Josephina A.M.A. Gadet ORCID,Gordon J. Freeman ORCID,E. Antonio Chiocca ORCID,Marco Mineo ORCID,Shikha Saini ORCID

Live enrichment

PubMed:40035950 OpenAlex:https://openalex.org/W4408156395

National Institutes of Health

Grant: P01CA236749

National Institutes of Health

Grant: 1P01CA236749-01A1

Understanding and Overcoming T cell Immunosuppression in Glioblastoma

National Institutes of Health

Grant: 1R01NS134723-01A1

Improving IL12 Immunogene Therapy for Glioblastoma Based on Human Clinical Trial Results

FWCI

2.99

Citation Percentile

0.9%

Citation Trend

2025

2026

hybridLicense: cc-by

journalhttps://doi.org/10.1007/s11060-025-04978-2

HYBRIDhttps://doi.org/10.1007/s11060-025-04978-2

publisherhttps://doi.org/10.1007/s11060-025-04978-2

publisherhttps://link.springer.com/content/pdf/10.1007/s11060-025-04978-2.pdf

publisherhttps://link.springer.com/article/10.1007/s11060-025-04978-2/fulltext.html

Fields of Study

Cancer-related molecular mechanisms researchGlioma Diagnosis and TreatmentCancer Immunotherapy and BiomarkersMedicineBiology03 medical and health sciences0302 clinical medicine

MeSH Terms

Brain NeoplasmsGlioblastomaHumansImmunotherapyGenetic TherapyGene Expression Regulation, NeoplasticInterleukin-12B7-H1 AntigenRNA, Long Noncoding

Keywords

Interleukin 12Gene silencingImmune systemCancer researchImmunotherapyImmunologyBiologyCytotoxic T cellGeneIn vitroGene Expression Regulation, NeoplasticBrain NeoplasmsResearchHumansRNA, Long NoncodingGenetic TherapyGlioblastomaInterleukin-12B7-H1 Antigen

Sustainable Development Goals

SDG 0: Good health and well-being